Nepal bans sale of Indian antibiotic injection, surprising reason came to the fore

Recently a big decision has been taken in Nepal. The Drug Administration Department of the country has banned the sale and distribution of antibiotic injection Biotax made by an Indian company. It is natural to have a question in the mind after reading this, what is the reason for doing this? According to tests carried out in the National Drug Regulatory Body laboratory in Nepal, the drug/injection Biotax - 1-gramme batch F300460 manufactured by Zydus Healthcare Limited, an Indian pharmaceutical business, was not produced in accordance with the specifications. Its import has likewise been halted in this scenario.

According to information provided by Patrika, using Biotax injections could put patients' lives in jeopardy. This was said by a representative of the Department of Medicines of Nepal. It was necessary to prohibit its sale and distribution in such a situation, as stated by the Department of Medicines in Nepal.

According to the report, Biotax 1 gram injection is an antibiotic injection. This injection is used to treat bacterial infections including in organs such as the brain, blood and heart, lungs, ears, skin, bones and joints, urinary tract, and soft tissues of patients. Not only this, this injection is also used to prevent possible infection during surgery.